Lucid Diagnostics Inc Quick Ratio (LUCD) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Lucid Diagnostics Inc   (NASDAQ: LUCD)

Lucid Diagnostics Inc 's Quick Ratio

LUCD's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Lucid Diagnostics Inc 's Cash & cash equivalent grew by 19.83 % in the Q2 2026 sequentially, while Current Liabilities decreased, this led to improvement in Lucid Diagnostics Inc 's Quick Ratio to 1.21, Quick Ratio remained below Lucid Diagnostics Inc average.

Within Medical Equipment & Supplies industry 104 other companies have achieved higher Quick Ratio than Lucid Diagnostics Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 1658 to 1672.

Explain Quick Ratio?
How much Cash & cash equivalents LUCD´s has?
What are LUCD´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LUCD Quick Ratio (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2
Y / Y Current Liabilities Change -6.49 % -22.13 % 5.07 % 83.91 % 84.14 %
Y / Y Cash & cash equivalent Change 7.33 % 10.45 % 55.22 % 226.68 % 24.89 %
Quick Ratio MRQ 1.21 0.98 1.25 1.81 1.06
LUCD's Total Ranking # 1672 # 1658 # 1515 # 722 # 1411
Seq. Current Liabilities Change -3.37 % 2.85 % 5.66 % -10.94 % -19.53 %
Seq. Cash & cash equivalent Change 19.83 % -19.68 % -26.68 % 52.08 % 23.32 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 105
Healthcare Sector # 597
Overall Market # 1672


Quick Ratio Statistics
High Average Low
36.01 3.1 0
(Dec 31 2021)   (Sep 30 2021)




Financial Statements
Lucid Diagnostics Inc 's Current Liabilities $ 28 Millions Visit LUCD's Balance sheet
Lucid Diagnostics Inc 's Cash & cash equivalent $ 33 Millions Visit LUCD's Balance sheet
Source of LUCD's Sales Visit LUCD's Sales by Geography


Cumulative Lucid Diagnostics Inc 's Quick Ratio

LUCD's Quick Ratio for the trailling 12 Months

LUCD Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 3.09 % 20.02 % 56.6 % 48.96 % 11.55 %
Y / Y Cash & cash equivalent TTM Growth 53.76 % 62.1 % 59.93 % 51.73 % 0.62 %
Quick Ratio TTM 1.3 1.26 1.15 1.06 0.87
Total Ranking TTM # 4015 # 3097 # 2979 # 2047 # 3058
Seq. Current Liabilities TTM Growth -1.71 % -6.75 % 1.13 % 11.22 % 14.43 %
Seq. Cash & cash equivalent TTM Growth 1.62 % 1.91 % 9.8 % 35.24 % 7.13 %

Quick ratio ranking by company, industry and sector >> Back to LUCD Financial Strength Comparisons >> Go to Compare LUCD Quick Ratio to its Competitors

On the trailing twelve months basis LUCD Cash & cash equivalent improved by 7.33 % in Q2 2026 year on year, while Current Liabilities decreased to $28 millions, this led to increase in in Lucid Diagnostics Inc 's Quick Ratio to 1.3, Quick Ratio remained below LUCD average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 201 other companies have achieved higher Quick Ratio than Lucid Diagnostics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 3097 to 4015.

Explain Quick Ratio?
How much Cash & cash equivalents LUCD´s has?
What are LUCD´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 202
Healthcare Sector # 896
Within the Market # 4015


trailing twelve months Quick Ratio Statistics
High Average Low
4.48 1.65 0.9
(Sep 30 2022)   (Jun 30 2025)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Inspiremd Inc   3.15 $ 30.421  Millions$ 9.646  Millions
Fractyl Health Inc   3.00 $ 47.140  Millions$ 15.736  Millions
Vivani Medical Inc   2.99 $ 19.894  Millions$ 6.659  Millions
Retractable Technologies Inc  2.98 $ 39.870  Millions$ 13.365  Millions
Neuropace Inc   2.97 $ 51.700  Millions$ 17.433  Millions
Apyx Medical Corp  2.95 $ 27.617  Millions$ 9.354  Millions
Omada Health Inc   2.94 $ 221.712  Millions$ 75.483  Millions
Clearpoint Neuro Inc   2.85 $ 29.363  Millions$ 10.313  Millions
Penumbra Inc  2.82 $ 658.795  Millions$ 233.776  Millions
Glaukos Corp  2.80 $ 286.594  Millions$ 102.329  Millions
Pulmonx Corporation  2.76 $ 56.393  Millions$ 20.405  Millions
Intuitive Surgical Inc   2.71 $ 5,216.200  Millions$ 1,922.900  Millions
Neuraxis Inc   2.69 $ 8.342  Millions$ 3.096  Millions
Edwards Lifesciences Corporation  2.68 $ 4,291.700  Millions$ 1,604.100  Millions
Modular Medical Inc  2.63 $ 3.920  Millions$ 1.489  Millions
Co diagnostics Inc   2.55 $ 7.299  Millions$ 2.863  Millions
Staar Surgical Co  2.47 $ 181.489  Millions$ 73.394  Millions
Electromed Inc   2.35 $ 20.450  Millions$ 8.714  Millions
EBR Systems, Inc.  2.18 $ 113.533  Millions$ 52.023  Millions
Medinotec Inc   2.15 $ 2.519  Millions$ 1.171  Millions
Atricure Inc   2.05 $ 167.786  Millions$ 81.916  Millions
Tactile Systems Technology Inc   1.83 $ 69.853  Millions$ 38.253  Millions
Tandem Diabetes Care Inc   1.80 $ 455.996  Millions$ 253.005  Millions
Inspire Medical Systems inc   1.79 $ 127.761  Millions$ 71.282  Millions
Warby Parker Inc   1.79 $ 292.674  Millions$ 163.480  Millions
Capsovision Inc   1.76 $ 9.077  Millions$ 5.158  Millions
Anika Therapeutics Inc   1.73 $ 38.412  Millions$ 22.147  Millions
Genedx Holdings Corp   1.71 $ 132.548  Millions$ 77.648  Millions
Beta Bionics Inc   1.70 $ 44.318  Millions$ 26.017  Millions
Merit Medical Systems Inc  1.70 $ 450.906  Millions$ 264.933  Millions

Date modified: 2026-09-26T07:41:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.